Craig-Hallum Keeps Their Buy Rating on CareDx (CDNA)
Craig-Hallum's William Bonello reiterated a Buy rating for CareDx (CDNA) with a $26.00 price target. Bonello, who covers the Healthcare sector, has a 31.6% average return and a 63.47% success rate on stocks. CareDx also received a Buy rating from TR | OpenAI – 4o’s Cira Diagnissa, while H.C. Wainwright maintained a Hold rating.
In a report released today, William Bonello from Craig-Hallum reiterated a Buy rating on CareDx, with a price target of $26.00.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Bonello covers the Healthcare sector, focusing on stocks such as Exact Sciences, SOPHiA GENETICS, and NeoGenomics. According to TipRanks, Bonello has an average return of 31.6% and a 63.47% success rate on recommended stocks.
In addition to Craig-Hallum, CareDx also received a Buy from TR | OpenAI – 4o’s Cira Diagnissa in a report issued on November 10. However, on the same day, H.C. Wainwright reiterated a Hold rating on CareDx (NASDAQ: CDNA).
